Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism

Clinical trial NCT02585713 · COMPLETED

Trial details

NCT number: NCT02585713
Sponsor: Academic and Community Cancer Research United
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Cerebral Vein Thrombosis Deep Vein Thrombosis Gonadal Thrombosis Hepatic Thrombosis Malignant Neoplasm Mesenteric Thrombosis Metastatic Malignant Neoplasm Portal Vein Thrombosis Pulmonary Embolism Renal Vein Thrombosis Splenic Thrombosis Venous Thromboembolism

Start date: 2015-11-20
Primary completion: 2018-04-02
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.